7q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium

Research output: Contribution to journalJournal articleResearchpeer-review

  • Roger L Milne
  • Justo Lorenzo-Bermejo
  • Barbara Burwinkel
  • Núria Malats
  • Jose Ignacio Arias
  • M Pilar Zamora
  • Javier Benítez
  • Manjeet K Humphreys
  • Montserrat García-Closas
  • Stephen J Chanock
  • Jolanta Lissowska
  • Mark E Sherman
  • Arto Mannermaa
  • Vesa Kataja
  • Veli-Matti Kosma
  • Heli Nevanlinna
  • Tuomas Heikkinen
  • Kristiina Aittomäki
  • Carl Blomqvist
  • Hoda Anton-Culver
  • Argyrios Ziogas
  • Peter Devilee
  • Christie J van Asperen
  • Rob A E M Tollenaar
  • Caroline Seynaeve
  • Per Hall
  • Kamila Czene
  • Jianjun Liu
  • Astrid K Irwanto
  • Daehee Kang
  • Keun-Young Yoo
  • Dong-Young Noh
  • Fergus J Couch
  • Janet E Olson
  • Xianshu Wang
  • Zachary Fredericksen
  • Nordestgaard, Børge
  • Bojesen, Stig Egil
  • Henrik Flyger
  • Sara Margolin
  • Annika Lindblom
  • Peter A Fasching
  • Ruediger Schulz-Wendtland
  • Arif B Ekici
  • Matthias W Beckmann
  • Shan Wang-Gohrke
  • Chen-Yang Shen
  • Jyh-Cherng Yu
  • Huan-Ming Hsu
  • Pei-Ei Wu
  • AOCS Group
Using the Breast Cancer Association Consortium, the authors previously reported that the single nucleotide polymorphism 7q21-rs6964587 (AKAP9-M463I) is associated with breast cancer risk. The authors have now assessed this association more comprehensively using 16 independent case-control studies.
Original languageEnglish
JournalJournal of Medical Genetics
Volume48
Issue number10
Pages (from-to)698-702
Number of pages5
ISSN0022-2593
DOIs
Publication statusPublished - 2011

ID: 40184190